Lucia I. Sue
About
Lucia I. Sue is a scholar working on Physiology, Neurology and Molecular Biology.
According to data from OpenAlex, Lucia I. Sue has authored 127 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Physiology, 63 papers in Neurology and 31 papers in Molecular Biology. Recurrent topics in Lucia I. Sue's work include Alzheimer's disease research and treatments (62 papers), Parkinson's Disease Mechanisms and Treatments (60 papers) and Dementia and Cognitive Impairment Research (29 papers). Lucia I. Sue is often cited by papers focused on Alzheimer's disease research and treatments (62 papers), Parkinson's Disease Mechanisms and Treatments (60 papers) and Dementia and Cognitive Impairment Research (29 papers). Lucia I. Sue collaborates with scholars based in United States, Japan and Canada. Lucia I. Sue's co-authors include Thomas G. Beach, Douglas G. Walker, Marwan N. Sabbagh, Alex E. Roher, Charles H. Adler, Holly A. Shill, John N. Caviness, Yu‐Min Kuo, Geidy E. Serrano and Lih‐Fen Lue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
In The Last Decade
Lucia I. Sue
127 papers receiving 9.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lucia I. Sue United States | 53 | 5.1k | 3.9k | 2.3k | 2.1k | 1.8k | 127 | 9.9k | ||
| Marwan N. Sabbagh United States | 53 | 3.9k 0.8× | 4.4k 1.1× | 2.0k 0.9× | 1.8k 0.9× | 1.7k 1.0× | 200 | 10.1k | ||
| Michael Hutton United States | 48 | 5.3k 1.0× | 2.6k 0.7× | 2.9k 1.2× | 1.9k 0.9× | 1.8k 1.0× | 107 | 8.2k | ||
| Annemieke J.M. Rozemüller Netherlands | 59 | 5.9k 1.2× | 2.8k 0.7× | 4.6k 2.0× | 3.8k 1.8× | 2.1k 1.2× | 238 | 12.8k | ||
| Alberto Lleó Spain | 48 | 4.1k 0.8× | 1.8k 0.5× | 2.3k 1.0× | 1.3k 0.6× | 1.1k 0.6× | 224 | 7.6k | ||
| Eileen H. Bigio United States | 47 | 6.7k 1.3× | 4.6k 1.2× | 3.5k 1.5× | 2.5k 1.2× | 1.8k 1.0× | 144 | 12.6k | ||
| Douglas G. Walker United States | 64 | 6.4k 1.3× | 2.9k 0.7× | 3.9k 1.7× | 5.1k 2.5× | 2.0k 1.1× | 173 | 13.7k | ||
| Miloš D. Ikonomović United States | 50 | 4.8k 0.9× | 1.6k 0.4× | 2.5k 1.1× | 1.6k 0.8× | 2.1k 1.2× | 162 | 9.0k | ||
| Irina Alafuzoff Sweden | 61 | 6.9k 1.4× | 3.8k 1.0× | 4.4k 1.9× | 2.6k 1.3× | 3.8k 2.1× | 205 | 14.2k | ||
| Johannes Attems United Kingdom | 57 | 5.2k 1.0× | 3.8k 1.0× | 2.3k 1.0× | 2.9k 1.4× | 1.4k 0.8× | 190 | 11.0k | ||
| Estifanos Ghebremedhin Germany | 32 | 3.3k 0.7× | 3.2k 0.8× | 1.4k 0.6× | 1.6k 0.7× | 1.6k 0.9× | 59 | 7.2k |
Countries citing papers authored by Lucia I. Sue
Since
Specialization
Citations
This map shows the geographic impact of Lucia I. Sue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia I. Sue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia I. Sue more than expected).
Fields of papers citing papers by Lucia I. Sue
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lucia I. Sue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia I. Sue. The network helps show where Lucia I. Sue may publish in the future.
Co-authorship network of co-authors of Lucia I. Sue
This figure shows the co-authorship network connecting the top 25 collaborators of Lucia I. Sue. A scholar is included among the top collaborators of Lucia I. Sue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia I. Sue. Lucia I. Sue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Qian, Alexander D. Borowsky, Thomas G. Beach, et al.. (2023). Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease. Neuroscience Letters. 810. 137330–137330.
2.
Adler, Charles H., Nan Zhang, Geidy E. Serrano, et al.. (2022). Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson's Disease: An Update.. PubMed. 19(10-12). 19–23.
3.
Tooyama, Ikuo, Jean‐Pierre Bellier, Geidy E. Serrano, et al.. (2019). Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology. Acta Neuropathologica Communications. 7(1). 215–215.
4.
Adler, Charles H., Geidy E. Serrano, Nan Zhang, et al.. (2019). Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease. Parkinsonism & Related Disorders. 68. 69–72.
5.
Piras, Ignazio S., Isabelle Schrauwen, Jason J. Corneveaux, et al.. (2017). Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway. Hippocampus. 27(7). 784–793.
6.
Walker, Douglas G., Lih-Fen Lue, Geidy E. Serrano, et al.. (2016). Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases. Frontiers in Neuroscience. 9. 507–507.
7.
Adler, Charles H., Thomas G. Beach, Joseph G. Hentz, et al.. (2014). Low clinical diagnostic accuracy of early vs advanced Parkinson disease. Neurology. 83(5). 406–412.
8.
Dugger, Brittany N., Joseph G. Hentz, Charles H. Adler, et al.. (2014). Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers. Journal of Neuropathology & Experimental Neurology. 73(3). 244–252.
9.
Malek‐Ahmadi, Michael, Charles H. Adler, Holly A. Shill, et al.. (2013). Prevalence of hippocampal sclerosis in a clinicopathologically characterized cohort. PubMed. 1(7). 317–327.
10.
Evidente, Virgilio Gerald H., Charles H. Adler, Marwan N. Sabbagh, et al.. (2011). Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?. Parkinsonism & Related Disorders. 17(5). 365–371.
11.
Potter, Pamela E., et al.. (2011). Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease. Acta Neuropathologica. 122(1). 49–60.
12.
Kokjohn, Tyler A., Gregory D. Van Vickle, Chera L. Maarouf, et al.. (2011). Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1508–1514.
13.
Beach, Thomas G., Charles L. White, Christa L. Hladik, et al.. (2008). Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathologica. 117(2). 169–74.
14.
Callaghan, Debbie, Jianying Bai, Aimee Jones, et al.. (2008). P4‐182: Inhibition of ABCG2 transport function by amyloid‐beta peptide augments cellular oxidative stress and inflammatory gene expression in cells. Alzheimer s & Dementia. 4(4S_Part_22).
15.
Beach, Thomas G., Charles H. Adler, Lucia I. Sue, et al.. (2007). Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathologica. 115(4). 445–451.
16.
Beach, Thomas G., Jeffrey R. Wilson, Lucia I. Sue, et al.. (2006). Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathologica. 113(1). 13–21.
17.
Sabbagh, Marwan N., et al.. (2006). Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging. Archives of Neurology. 63(12). 1771–1771.
18.
Beach, Thomas G., Douglas G. Walker, Pamela E. Potter, Lucia I. Sue, & Abraham Fisher. (2001). Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists. Brain Research. 905(1-2). 220–223.
19.
Kuo, Yu‐Min, Tyler A. Kokjohn, Thomas G. Beach, et al.. (2001). Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains. Journal of Biological Chemistry. 276(16). 12991–12998.
20.
Kuo, Yu‐Min, Thomas G. Beach, Lucia I. Sue, et al.. (2001). The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease. Molecular Medicine. 7(9). 609–618.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marwan N. Sabbagh Breakdown of academic impact, for papers by Michael Hutton Breakdown of academic impact, for papers by Annemieke J.M. Rozemüller Breakdown of academic impact, for papers by Alberto Lleó Breakdown of academic impact, for papers by Eileen H. Bigio Breakdown of academic impact, for papers by Douglas G. Walker Breakdown of academic impact, for papers by Miloš D. Ikonomović Breakdown of academic impact, for papers by Irina Alafuzoff Breakdown of academic impact, for papers by Johannes Attems Breakdown of academic impact, for papers by Estifanos Ghebremedhin